Health In Tech (HIT) Cash & Equivalents (2023 - 2025)

Health In Tech has reported Cash & Equivalents for 3 years, with the latest figure at $7.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 2.29% year-over-year to $7.7 million; the trailing twelve-month figure through Dec 2025 stood at $7.7 million (down 2.29% YoY), and the FY2025 full-year result was $7.7 million, down 2.29% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $7.7 million, down from $8.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $8.1 million in Q2 2025, with the low at $2.4 million in Q4 2023.
• Average Cash & Equivalents over 3 years is $6.9 million, with a median of $7.8 million recorded in 2024.
• Year-over-year, Cash & Equivalents soared 224.84% in 2024 and declined 2.29% in 2025.
• Tracing HIT's Cash & Equivalents over 3 years: stood at $2.4 million in 2023, then soared by 224.84% to $7.8 million in 2024, then declined by 2.29% to $7.7 million in 2025.
• The last three Cash & Equivalents figures came in at $7.7 million (Q4 2025), $8.0 million (Q3 2025), and $8.1 million (Q2 2025), per Business Quant data.

Peer Comparison